The European Commission has released evaluation results showing that three Enterprise Ireland-backed companies have been selected and approved for a total of €24.3m in funding from the European Innovation Council (EIC) Accelerator Programme.
The three successful Irish companies are ATXA Therapeutics, Peregrine Technologies and Ostoform Limited. The successful Irish led projects cover areas including accelerating the clinical path of a disea modifying drug targeting cardiopulmonary disease; AI development and robotics targeting the WEEE recycling sector and the development of a novel appliance to improve the skin condition of ostomy bag users.
Leo Clancy, CEO, Enterprise Ireland said: “Enterprise Ireland welcomes this announcement by EIC. It is a great success for Ireland and is testament to the capability and talent within the Irish research and innovation system. Start-ups, particularly in the deep-tech sector play a critical role in the development and growth of regional innovation ecosystems. The three successful Enterprise Ireland applicants, working with the EIC, will be able to enhance their entrepreneurial capability and get the critical support required at this juncture in their development and scaling journey.” Find out more:
Call me back 
